Results
1
-
2
of
2
[DOI: 10.1021/jm901281m]
Lucerastat, an iminosugar with potential as substrate reduction therapy for glycolipid storage disorders: safety, tolerability, and pharmacokinetics in healthy subjects
,
Orphanet Journal of Rare Diseases
[DOI: 10.1186/s13023-017-0565-9]